Details
Stereochemistry | ABSOLUTE |
Molecular Formula | 2C4H2O6.2K.2Sb.3H2O |
Molecular Weight | 667.873 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O.O.O.[K+].[K+].[Sb+3].[Sb+3].[O-][C@H]([C@@H]([O-])C([O-])=O)C([O-])=O.[O-][C@H]([C@@H]([O-])C([O-])=O)C([O-])=O
InChI
InChIKey=WBTCZEPSIIFINA-MSFWTACDSA-J
InChI=1S/2C4H4O6.2K.3H2O.2Sb/c2*5-1(3(7)8)2(6)4(9)10;;;;;;;/h2*1-2H,(H,7,8)(H,9,10);;;3*1H2;;/q2*-2;2*+1;;;;2*+3/p-4/t2*1-,2-;;;;;;;/m11......./s1
Molecular Formula | Sb |
Molecular Weight | 121.76 |
Charge | 3 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | K |
Molecular Weight | 39.0983 |
Charge | 1 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C4H4O6 |
Molecular Weight | 148.071 |
Charge | -2 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Molecular Formula | HO |
Molecular Weight | 17.0073 |
Charge | -1 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://www.whocc.no/atcvet/atcvet_index/?code=QR05CA07https://www.ncbi.nlm.nih.gov/pubmed/5295139 | https://www.ncbi.nlm.nih.gov/pubmed/14851220 | https://www.ncbi.nlm.nih.gov/pubmed/8898332Curator's Comment: description was created based on several sources, including https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7ef48d40-6d63-440b-a73c-46d89f425936
Sources: https://www.whocc.no/atcvet/atcvet_index/?code=QR05CA07https://www.ncbi.nlm.nih.gov/pubmed/5295139 | https://www.ncbi.nlm.nih.gov/pubmed/14851220 | https://www.ncbi.nlm.nih.gov/pubmed/8898332
Curator's Comment: description was created based on several sources, including https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7ef48d40-6d63-440b-a73c-46d89f425936
Stibophen (Fuadin), an organic trivalent antimony compound, has been used for many years in the treatment of schistosomiasis. Stibophen is used as treatment of schistosomiasis by intramuscular injection. Stibophen is known to act by selectively inhibiting worm PFK.
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 16 17:44:44 UTC 2022
by
admin
on
Fri Dec 16 17:44:44 UTC 2022
|
Record UNII |
DL6OZ476V3
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C737
Created by
admin on Fri Dec 16 17:44:44 UTC 2022 , Edited by admin on Fri Dec 16 17:44:44 UTC 2022
|
||
|
EPA PESTICIDE CODE |
6201
Created by
admin on Fri Dec 16 17:44:44 UTC 2022 , Edited by admin on Fri Dec 16 17:44:44 UTC 2022
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
ANTIMONY POTASSIUM TARTRATE
Created by
admin on Fri Dec 16 17:44:44 UTC 2022 , Edited by admin on Fri Dec 16 17:44:44 UTC 2022
|
PRIMARY | |||
|
DTXSID3039240
Created by
admin on Fri Dec 16 17:44:44 UTC 2022 , Edited by admin on Fri Dec 16 17:44:44 UTC 2022
|
PRIMARY | |||
|
28300-74-5
Created by
admin on Fri Dec 16 17:44:44 UTC 2022 , Edited by admin on Fri Dec 16 17:44:44 UTC 2022
|
PRIMARY | |||
|
DL6OZ476V3
Created by
admin on Fri Dec 16 17:44:44 UTC 2022 , Edited by admin on Fri Dec 16 17:44:44 UTC 2022
|
PRIMARY | |||
|
M1961
Created by
admin on Fri Dec 16 17:44:44 UTC 2022 , Edited by admin on Fri Dec 16 17:44:44 UTC 2022
|
PRIMARY | Merck Index | ||
|
C76863
Created by
admin on Fri Dec 16 17:44:44 UTC 2022 , Edited by admin on Fri Dec 16 17:44:44 UTC 2022
|
PRIMARY | |||
|
1428
Created by
admin on Fri Dec 16 17:44:44 UTC 2022 , Edited by admin on Fri Dec 16 17:44:44 UTC 2022
|
PRIMARY | |||
|
2761
Created by
admin on Fri Dec 16 17:44:44 UTC 2022 , Edited by admin on Fri Dec 16 17:44:44 UTC 2022
|
PRIMARY | |||
|
981
Created by
admin on Fri Dec 16 17:44:44 UTC 2022 , Edited by admin on Fri Dec 16 17:44:44 UTC 2022
|
PRIMARY | RxNorm | ||
|
SUB34747
Created by
admin on Fri Dec 16 17:44:44 UTC 2022 , Edited by admin on Fri Dec 16 17:44:44 UTC 2022
|
PRIMARY | |||
|
73415808
Created by
admin on Fri Dec 16 17:44:44 UTC 2022 , Edited by admin on Fri Dec 16 17:44:44 UTC 2022
|
PRIMARY | |||
|
DB15587
Created by
admin on Fri Dec 16 17:44:44 UTC 2022 , Edited by admin on Fri Dec 16 17:44:44 UTC 2022
|
PRIMARY | |||
|
SUB127075
Created by
admin on Fri Dec 16 17:44:44 UTC 2022 , Edited by admin on Fri Dec 16 17:44:44 UTC 2022
|
ALTERNATIVE | |||
|
SUB12916MIG
Created by
admin on Fri Dec 16 17:44:44 UTC 2022 , Edited by admin on Fri Dec 16 17:44:44 UTC 2022
|
PRIMARY | |||
|
DL6OZ476V3
Created by
admin on Fri Dec 16 17:44:44 UTC 2022 , Edited by admin on Fri Dec 16 17:44:44 UTC 2022
|
PRIMARY | |||
|
D000966
Created by
admin on Fri Dec 16 17:44:44 UTC 2022 , Edited by admin on Fri Dec 16 17:44:44 UTC 2022
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ANHYDROUS->SOLVATE | |||
|
PARENT -> SALT/SOLVATE | |||
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |